Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Kleijnen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 12, 2013
['Fitting' evidence preferable when evaluating effectiveness of interventions]Juanita M Heymans, Sarah Kleijnen, Ilse M Verstijnen
International Journal of Technology Assessment in Health Care|March 10, 2015
Comparing the hta core model with a national health technology assessment reportIris Pasternack, Ingrid de Groot, Sarah Kleijnen, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 11, 2015
[HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality]Anna Nachtnebel, Julia Mayer, Judit Erdös, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 13, 2017
The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countriesSarah Kleijnen, Teresa Leonardo Alves, Kim Meijboom, et al.
BMJ Open|July 30, 2015
Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makersSaskia de Groot, Adriana J Rijnsburger, Matthijs M Versteegh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib AssessmentsSarah Kleijnen, Mohammed Fathallah, Michiel W van der Linden, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Developing the HTA core model for the online environmentKristian Lampe, Iris Pasternack, Oskari Saarekas, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Standardized reporting for rapid relative effectiveness assessments of pharmaceuticalsSarah Kleijnen, Iris Pasternack, Marc Van de Casteele, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictionsSarah Kleijnen, Elisabeth George, Scott Goulden, et al.
Health Policy (Amsterdam, Netherlands)|February 24, 2015
European collaboration on relative effectiveness assessments: What is needed to be successful?Sarah Kleijnen, Wil Toenders, Folkert de Groot, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|April 12, 2013
['Fitting' evidence preferable when evaluating effectiveness of interventions]Juanita M Heymans, Sarah Kleijnen, Ilse M Verstijnen
International Journal of Technology Assessment in Health Care|March 10, 2015
Comparing the hta core model with a national health technology assessment reportIris Pasternack, Ingrid de Groot, Sarah Kleijnen, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 11, 2015
[HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality]Anna Nachtnebel, Julia Mayer, Judit Erdös, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 13, 2017
The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countriesSarah Kleijnen, Teresa Leonardo Alves, Kim Meijboom, et al.
BMJ Open|July 30, 2015
Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makersSaskia de Groot, Adriana J Rijnsburger, Matthijs M Versteegh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib AssessmentsSarah Kleijnen, Mohammed Fathallah, Michiel W van der Linden, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Developing the HTA core model for the online environmentKristian Lampe, Iris Pasternack, Oskari Saarekas, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Standardized reporting for rapid relative effectiveness assessments of pharmaceuticalsSarah Kleijnen, Iris Pasternack, Marc Van de Casteele, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictionsSarah Kleijnen, Elisabeth George, Scott Goulden, et al.
Health Policy (Amsterdam, Netherlands)|February 24, 2015
European collaboration on relative effectiveness assessments: What is needed to be successful?Sarah Kleijnen, Wil Toenders, Folkert de Groot, et al.
Pageof 2